Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.

Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.

A previously presented physiologically-based pharmacokinetic model for immediate release (IR) methylphenidate (MPH) was extended to characterize the pharmacokinetic behaviors of oral extended release (ER) MPH formulations in adults for the first time. Information on the anatomy and physiology of the...

Bibliográfalaš dieđut
Váldodahkkit:	Xiaoxia Yang, John Duan, Jeffrey Fisher
Materiálatiipa:	Artihkal
Giella:	English
Almmustuhtton:	Public Library of Science (PLoS) 2016-01-01
Ráidu:	PLoS ONE
Liŋkkat:	http://europepmc.org/articles/PMC5056674?pdf=render

Geahča maid

Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates.
Dahkki: Xiaoxia Yang, et al.
Almmustuhtton: (2014-01-01)

Use of physiologically‐based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended‐release nifedipine
Dahkki: Ming‐Liang Tan, et al.
Almmustuhtton: (2024-02-01)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
Dahkki: Xiaoxia eYang, et al.
Almmustuhtton: (2015-01-01)

Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate.
Dahkki: Jurjen van der Schans, et al.
Almmustuhtton: (2015-01-01)

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists
Dahkki: Caballero J, et al.
Almmustuhtton: (2017-10-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
Dahkki: Armagan Aral, et al.
Almmustuhtton: (2022-08-01)

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
Dahkki: Landgraf Jeanne M, et al.
Almmustuhtton: (2009-12-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
Dahkki: John S. Markowitz, et al.
Almmustuhtton: (2022-11-01)

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule
Dahkki: Pawan Kumar Gupta, et al.
Almmustuhtton: (2024-01-01)

Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Dahkki: Louis Lin, et al.
Almmustuhtton: (2017-09-01)

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
Dahkki: Farr SJ, et al.
Almmustuhtton: (2015-01-01)

Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool
Dahkki: Lisa Cheng, et al.
Almmustuhtton: (2020-07-01)

Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder
Dahkki: Babajide Shenkoya, et al.
Almmustuhtton: (2024-11-01)

Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug
Dahkki: Shiwen Song, et al.
Almmustuhtton: (2023-08-01)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
Dahkki: Nagsen Gautam, et al.
Almmustuhtton: (2021-06-01)

Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
Dahkki: Alfredo Durand-Rivera, et al.
Almmustuhtton: (2015-01-01)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
Dahkki: Rafał Bieś, et al.
Almmustuhtton: (2023-09-01)

Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics
Dahkki: Luiza de Oliveira Macedo, et al.
Almmustuhtton: (2024-08-01)

Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Dahkki: Sandor-Adrian Klis, et al.
Almmustuhtton: (2024-08-01)

Predicting absorption and pharmacokinetic profile of carbamazepine from controlled-release tablet formulation in humans using rabbit model
Dahkki: Homšek Irena, et al.
Almmustuhtton: (2011-01-01)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
Dahkki: Jan K Buitelaar, et al.
Almmustuhtton: (2009-08-01)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
Dahkki: Fang Chen, et al.
Almmustuhtton: (2020-02-01)

Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
Dahkki: Saima Subhani, et al.
Almmustuhtton: (2023-02-01)

Pharmacokinetic and drug absorption profiles of the anti-hyperglycaemic agent gliclazide in oral tissue-targeted microcapsules in rats
Dahkki: Jović Jelena, et al.
Almmustuhtton: (2020-01-01)

Methylphenidate enhances implicit learning in healthy adults
Dahkki: Klinge, C, et al.
Almmustuhtton: (2017)

Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus)
Dahkki: Niora J. Fabian, et al.
Almmustuhtton: (2023-07-01)

Application of Physiologically Based Pharmacokinetic Models in Chemical Risk Assessment
Dahkki: Moiz Mumtaz, et al.
Almmustuhtton: (2012-01-01)

Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
Dahkki: Cindy X. Zhang, et al.
Almmustuhtton: (2024-03-01)

Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process
Dahkki: Edilainy Rizzieri Caleffi‐Marchesini, et al.
Almmustuhtton: (2024-02-01)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
Dahkki: Yoo-Kyung Song, et al.
Almmustuhtton: (2021-03-01)

Effect of Oral Methylphenidate on the Experimental Epileptiform Activity in Male Rats
Dahkki: Yousef Panahi, et al.
Almmustuhtton: (2020-01-01)

Methylphenidate Abuse
Dahkki: J Gordon Millichap
Almmustuhtton: (1994-11-01)

Methylphenidate and Seizures
Dahkki: J Gordon Millichap
Almmustuhtton: (1989-10-01)

Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans
Dahkki: Chen L, et al.
Almmustuhtton: (2015-06-01)

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
Dahkki: Hammerness Paul, et al.
Almmustuhtton: (2007-09-01)

A Physiologically‐Based Pharmacokinetic Model for the Prediction of “Half‐Life Extension” and “Catch and Release” Monoclonal Antibody Pharmacokinetics
Dahkki: Hannah M. Jones, et al.
Almmustuhtton: (2020-09-01)

Absorption profile fitting tests on data release.
Dahkki: Rogers, Alan E.E.
Almmustuhtton: (2024)

Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
Dahkki: Youran Xu, et al.
Almmustuhtton: (2023-01-01)

Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
Dahkki: Franke RM, et al.
Almmustuhtton: (2015-08-01)

Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets
Dahkki: Swiss Medical Weekly
Almmustuhtton: (2011-09-01)